Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro

被引:27
|
作者
Ozaki, Masahiro [1 ,2 ]
Iwanami, Akio [1 ]
Nagoshi, Narihito [1 ]
Kohyama, Jun [2 ]
Itakura, Go [1 ,2 ]
Iwai, Hiroki [1 ]
Nishimura, Soraya [1 ]
Nishiyama, Yuichiro [1 ]
Kawabata, Soya [1 ]
Sugai, Keiko [1 ]
Iida, Tsuyoshi [1 ]
Matsubayashi, Kohei [1 ]
Isoda, Miho [2 ,3 ]
Kashiwagi, Rei [1 ]
Toyama, Yoshiaki [1 ]
Matsumoto, Morio [1 ]
Okano, Hideyuki [2 ]
Nakamura, Masaya [1 ]
机构
[1] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan
[2] Keio Univ, Sch Med, Dept Physiol, Tokyo, Japan
[3] Sumitomo Dainippon Pharma Co Ltd, Regenerat & Cellular Med Off, Kobe, Hyogo, Japan
基金
日本科学技术振兴机构;
关键词
iPS cell-derived neural stem/progenitor cells HLA; Mixed lymphocyte reaction; Immunomodulatory function; PLURIPOTENT STEM-CELLS; SPINAL-CORD-INJURY; MESENCHYMAL STROMAL CELLS; FUNCTIONAL RECOVERY; T-CELLS; TRANSPLANTATION; EXPRESSION; NEURONS; DONOR; SURVIVAL;
D O I
10.1016/j.scr.2017.01.007
中图分类号
Q813 [细胞工程];
学科分类号
摘要
To achieve the goal of a first-in-human trial for human induced pluripotent stemcell (hiPSC)-based transplantation for the treatment of various diseases, allogeneic human leukocyte antigen (HLA)-matched hiPSC cell banks represent a realistic tool from the perspective of quality control and cost performance. Furthermore, considering the limited therapeutic time-window for acute injuries, including neurotraumatic injuries, an hiPSC cell bank is of potential interest. However, due to the relatively immunoprivileged environment of the central nervous system, it is unclear whether HLA matching is required in hiPSC-derived neural stem/progenitor cell (hiPSC-NS/PC) transplantation for the treatment of neurodegenerative diseases and neurotraumatic injuries. In this study, we evaluated the significance of HLA matching in hiPSC-NS/PC transplantation by performing modified mixed lymphocyte reaction (MLR) assays with hiPSC-NS/PCs. Compared to fetus-derived NS/PCs, the expression levels of human leukocyte antigen-antigen D related (HLA-DR) and co-stimulatory molecules on hiPSC-NS/PCs were significantly low, even with the addition of tumor necrosis factor-a (TNF alpha) and/or interferon-gamma (IFN gamma) to mimic the inflammatory environment surrounding transplanted hiPSC-NS/PCs in injured tissues. Interestingly, both the allogeneic HLA-matched and the HLA-mismatched responses were similarly low in the modified MLR assay. Furthermore, the autologous response was also similar to the allogeneic response. hiPSC-NS/PCs suppressed the proliferative responses of allogeneic HLA-mismatched peripheral blood mononuclear cells (PBMCs) in a dose-dependent manner. Thus, the low antigen-presenting function and immunosuppressive effects of hiPSC-NS/PCs result in a depressed immune response, even in an allogeneic HLA-mismatched setting. It is crucial to verify whether these in vitro results are reproducible in a clinical setting. (C) 2017 The Authors. Published by Elsevier B. V.
引用
收藏
页码:128 / 138
页数:11
相关论文
共 50 条
  • [1] In vivo monitoring of remnant undifferentiated neural cells following human iPS cell-derived neural stem/progenitor cells transplantation
    Taninnoto, Yuji
    Yamasaki, Tomoteru
    Nagoshi, Narihito
    Nishiyama, Yuichiro
    Nori, Satoshi
    Nishimura, Soraya
    Iida, Tsuyoshi
    Ozaki, Masahiro
    Tsuji, Osahiko
    Ji, Bin
    Aoki, Ichio
    Jinzaki, Masahiro
    Matsumoto, Morio
    Fujibayashi, Yasuhisa
    Zhang, Ming-Rong
    Nakamura, Masaya
    Okano, Hideyuki
    STEM CELLS TRANSLATIONAL MEDICINE, 2020, 9 (04) : 465 - 477
  • [2] Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells
    Go Itakura
    Masahiro Ozaki
    Narihito Nagoshi
    Soya Kawabata
    Yuichiro Nishiyama
    Keiko Sugai
    Tsuyoshi Iida
    Rei Kashiwagi
    Toshiki Ookubo
    Kaori Yastake
    Kohei Matsubayashi
    Jun Kohyama
    Akio Iwanami
    Morio Matsumoto
    Masaya Nakamura
    Hideyuki Okano
    Scientific Reports, 7
  • [3] Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells
    Itakura, Go
    Ozaki, Masahiro
    Nagoshi, Narihito
    Kawabata, Soya
    Nishiyama, Yuichiro
    Sugai, Keiko
    Iida, Tsuyoshi
    Kashiwagi, Rei
    Ookubo, Toshiki
    Yastake, Kaori
    Matsubayashi, Kohei
    Kohyama, Jun
    Iwanami, Akio
    Matsumoto, Morio
    Nakamura, Masaya
    Okano, Hideyuki
    SCIENTIFIC REPORTS, 2017, 7
  • [4] Antipsychotics promote neural differentiation of human iPS cell-derived neural stem cells
    Asada, Minoru
    Mizutani, Shuki
    Takagi, Masatoshi
    Suzuki, Hidenori
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 480 (04) : 615 - 621
  • [5] Neuroprotective Effects of Genome-Edited Human iPS Cell-Derived Neural Stem/Progenitor Cells on Traumatic Brain Injury
    Imai, Ryotaro
    Tamura, Ryota
    Yo, Masahiro
    Sato, Mizuto
    Fukumura, Mariko
    Takahara, Kento
    Kase, Yoshitaka
    Okano, Hideyuki
    Toda, Masahiro
    STEM CELLS, 2023, 41 (06) : 603 - 616
  • [6] Transplantation therapy of human iPS cell-derived dopamine neural progenitor cells for Parkinson's disease
    Nakamura, R.
    Oyama, G.
    Jo, T.
    Ishikawa, K.
    Nonaka, R.
    Shimo, Y.
    Akamatsu, W.
    Hattori, N.
    MOVEMENT DISORDERS, 2018, 33 : S273 - S273
  • [7] Immunogenicity of human embryonic stem cell-derived beta cells
    van der Torren, Cornelis R.
    Zaldumbide, Arnaud
    Duinkerken, Gaby
    Brand-Schaaf, Simone H.
    Peakman, Mark
    Stange, Geert
    Martinson, Laura
    Kroon, Evert
    Brandon, Eugene P.
    Pipeleers, Daniel
    Roep, Bart O.
    DIABETOLOGIA, 2017, 60 (01) : 126 - 133
  • [8] Immunogenicity of human embryonic stem cell-derived beta cells
    Cornelis R. van der Torren
    Arnaud Zaldumbide
    Gaby Duinkerken
    Simone H. Brand-Schaaf
    Mark Peakman
    Geert Stangé
    Laura Martinson
    Evert Kroon
    Eugene P. Brandon
    Daniel Pipeleers
    Bart O. Roep
    Diabetologia, 2017, 60 : 126 - 133
  • [9] Regulatory factors of neurite generation of human stem cell-derived neural progenitor cells
    Lilienberg, J.
    Hegyi, Z.
    Apati, A.
    Homolya, L.
    FEBS OPEN BIO, 2022, 12 : 133 - 134
  • [10] ASSESSMENT OF TUMORIGENIC POTENTIAL OF HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED NEURAL STEM/PROGENITOR CELLS
    Iida, Tsuyoshi
    Iwanami, Akio
    Kohyama, Jun
    Nagoshi, Narihito
    Matsumoto, Morio
    Okano, Hideyuki
    Nakamura, Masaya
    NEURO-ONCOLOGY, 2016, 18 : 184 - 184